form8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
______________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 15, 2008
______________________
Orthofix International N.V.
(Exact name of Registrant as specified in its charter)
|
Netherlands Antilles |
0-19961 |
N/A |
|
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
|
7 Abraham de Veerstraat
Curacao
Netherlands Antilles |
N/A |
|
(Address of principal executive offices) |
(Zip Code) |
______________________
Registrant’s telephone number, including area code: 011-59-99-465-8525
______________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
£ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
£ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
£ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
£ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01. Regulation FD Disclosure.
On December 15, 2008, Orthofix International N.V. (the “Company”) issued a press release regarding the completion by the Musculoskeletal Transplant Foundation (MTF) of a milestone under its development agreement with the Company. A copy of the press release is furnished herewith as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
|
99.1 |
Press release, dated December 15, 2008 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
Orthofix International N.V.
|
| |
By: |
/s/ Robert S. Vaters |
|
| |
|
Robert S. Vaters |
|
| |
|
Executive Vice President and Chief Financial Officer |
|
Date: December 15, 2008
EXHIBIT INDEX
|
|
Press release, dated December 15, 2008 |